Bida M, Miya T, Hull R, Dlamini Z
Front Immunol. 2024; 15:1497522.
PMID: 39712007
PMC: 11659259.
DOI: 10.3389/fimmu.2024.1497522.
Rahimi A, Malakoutikhah Z, Rahimmanesh I, Ferns G, Nedaeinia R, Ishaghi S
Cancer Cell Int. 2023; 23(1):312.
PMID: 38057843
PMC: 10702008.
DOI: 10.1186/s12935-023-03134-y.
Chhabra Y, Weeraratna A
Cell. 2023; 186(8):1580-1609.
PMID: 37059066
PMC: 11422789.
DOI: 10.1016/j.cell.2023.03.016.
Caron J, Han X, Lary C, Sathyanarayana P, Remick S, Ernstoff M
Oncol Rep. 2023; 49(2).
PMID: 36633146
PMC: 9868893.
DOI: 10.3892/or.2023.8481.
Kato K, Miyazawa H, Kawashiri S, Lambert D
J Oncol. 2022; 2022:5277440.
PMID: 36471888
PMC: 9719419.
DOI: 10.1155/2022/5277440.
Melanoma stimulates the proteolytic activity of HaCaT keratinocytes.
Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Kot M, Pietraszek-Gremplewicz K, Wilk D
Cell Commun Signal. 2022; 20(1):146.
PMID: 36123693
PMC: 9484146.
DOI: 10.1186/s12964-022-00961-w.
Blood-Lymphatic Integrated System with Heterogeneous Melanoma Spheroids via In-Bath Three-Dimensional Bioprinting for Modelling of Combinational Targeted Therapy.
Cho W, Ahn M, Kim B, Cho D
Adv Sci (Weinh). 2022; 9(29):e2202093.
PMID: 36026581
PMC: 9561777.
DOI: 10.1002/advs.202202093.
Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts.
Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Pietraszek-Gremplewicz K, Majkowski M, Kot M
Cell Commun Signal. 2022; 20(1):63.
PMID: 35538545
PMC: 9092709.
DOI: 10.1186/s12964-022-00871-x.
Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma.
Cerqueira O, Antunes F, Assis N, Cardoso E, Clavijo-Salomon M, Domingues A
Front Mol Biosci. 2022; 9:777775.
PMID: 35495634
PMC: 9048901.
DOI: 10.3389/fmolb.2022.777775.
Meaningful connections: Interrogating the role of physical fibroblast cell-cell communication in cancer.
Gardiner J, Cukierman E
Adv Cancer Res. 2022; 154:141-168.
PMID: 35459467
PMC: 9483832.
DOI: 10.1016/bs.acr.2022.01.004.
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.
Pena-Romero A, Orenes-Pinero E
Cancers (Basel). 2022; 14(7).
PMID: 35406451
PMC: 8996887.
DOI: 10.3390/cancers14071681.
Hepatoblastoma: Derived Exosomal LncRNA NEAT1 Induces BMSCs Differentiation into Tumor-Supporting Myofibroblasts via Modulating the miR-132/MMP9 Axis.
Hu Y, Zai H, Jiang W, Ou Z, Yao Y, Zhu Q
J Oncol. 2022; 2022:7630698.
PMID: 35300348
PMC: 8923764.
DOI: 10.1155/2022/7630698.
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?.
Varrone F, Mandrich L, Caputo E
Cancers (Basel). 2021; 13(22).
PMID: 34830940
PMC: 8616100.
DOI: 10.3390/cancers13225788.
Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma.
de Moura L, Ribeiro L, de Carvalho F, Rodrigues da Silva G, Lima Fernandes P, Brunetto S
Pharmaceutics. 2021; 13(10).
PMID: 34683846
PMC: 8537790.
DOI: 10.3390/pharmaceutics13101552.
Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma.
Fu Y, Saraswat A, Wei Z, Agrawal M, Dukhande V, Reznik S
Pharmaceutics. 2021; 13(7).
PMID: 34371697
PMC: 8308940.
DOI: 10.3390/pharmaceutics13071005.
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.
Romano V, Belviso I, Venuta A, Ruocco M, Masone S, Aliotta F
Int J Mol Sci. 2021; 22(10).
PMID: 34067929
PMC: 8157224.
DOI: 10.3390/ijms22105283.
Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.
Dratkiewicz E, Simiczyjew A, Mazurkiewicz J, Zietek M, Matkowski R, Nowak D
Cells. 2021; 10(4).
PMID: 33918883
PMC: 8070386.
DOI: 10.3390/cells10040862.
Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy.
Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Zietek M, Matkowski R, Nowak D
Int J Mol Sci. 2021; 22(2).
PMID: 33430277
PMC: 7825728.
DOI: 10.3390/ijms22020529.
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F, Sadozai H, Seyed Jafari S, Hunger R, Schenk M
Front Immunol. 2020; 11:2105.
PMID: 33013886
PMC: 7511547.
DOI: 10.3389/fimmu.2020.02105.
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment.
Avagliano A, Fiume G, Pelagalli A, Sanita G, Ruocco M, Montagnani S
Front Oncol. 2020; 10:722.
PMID: 32528879
PMC: 7256186.
DOI: 10.3389/fonc.2020.00722.